Pressures are growing to publish clinical trials

doi:10.1136/bmj.329.7473.1044-b

BMJ 2004;329:1044 (30 October), doi:10.1136/bmj.329.7473.1044-b

Letter

Pressures are growing to publish clinical trials

The first 150 words of the full text of this article appear below.

EDITOR—After the threat of a court case in New York, GlaxoSmithKlinehas announced that it will publish results of all its clinicaltrials on its website.^1
2 Eli Lilly recently made a similarannouncement, including a commitment to publish all findingsin peer reviewed journals.³

This will be welcome news to people such as Abrams and me, whohave been (independently) campaigning for this for some time.⁴Last year, following several years of consultation, a groupfrom within the pharmaceutical industry published guidelineson good publication practice for pharmaceutical companies.⁵One of the main recommendations was for companies to endeavourto publish the results of all clinical trials relating to theirmarketed products in peer reviewed journals.

We were careful to include the word "endeavour," since, ultimately,journal editors decide what gets published. However, with thegrowth of electronic journals we believe it is usually possibleto publish trials. . . . [Full text of this article]

Elizabeth Wager, publications consultant

Sideview, Princes Risborough, Buckinghamshire HP27 9DE liz@sideview.demon.co.uk

CiteULike

Complore

Connotea

Del.icio.us Add to Digg

Digg

StumbleUpon Add to Technorati

Technorati What's this?

Relevant Articles

BMJ statistical errors: Tim J Cole, Douglas Altman, Deborah Ashby, Mike Campbell, Jonathan Deeks, Stephen Evans, Hazel Inskip, Julie Morris, and Gordon Murray
BMJ 2004 329: 462. [Extract] [Full Text]